Elevated Osteoprotegerin Concentration Predicts Increased Risk of Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Elevated Osteoprotegerin Concentration Predicts Increased Risk of Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Introduction: Studies have shown inconsistent results regarding the association between osteoprotegerin (OPG) concentration and cardiovascular mortality in patients with chronic kidney disease (CKD). This systematic review and meta-analysis aims to investigate the association between OPG concentrati...

Full description

Bibliographic Details
Main Authors:	Qing-xiu Huang, Jian-bo Li, Naya Huang, Xiao-wen Huang, Yan-lin Li, Feng-xian Huang
Format:	Article
Language:	English
Published:	Karger Publishers 2020-07-01
Series:	Kidney & Blood Pressure Research
Subjects:	osteoprotegerin cardiovascular mortality chronic kidney disease meta-analysis
Online Access:	https://www.karger.com/Article/FullText/508978

Similar Items

Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease
by: M.M. Nascimento, et al.
Published: (2014-11-01)

Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01)

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
by: Kamińska J, et al.
Published: (2021-06-01)

Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function
by: Sílvia Collado, et al.
Published: (2017-09-01)

Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients
by: Changlei Guo, et al.
Published: (2013-01-01)

Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
by: Stella Bernardi, et al.
Published: (2017-07-01)

Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
by: F U Dzgoeva, et al.
Published: (2014-06-01)

Serum osteoprotegerin as an early marker of chronic kidney disease in hypertensive patients
by: Khaled A Elhefnawy, et al.
Published: (2019-01-01)

Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis
by: Qimei Luo, et al.
Published: (2019-01-01)

Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan
by: Yen-Cheng Chen, et al.
Published: (2017-10-01)

The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox
by: Flora Özkalaycı, et al.
Published: (2018-05-01)

Serum Osteoprotegerin level and the extent of cardiovascular calcification in haemodialysis patients
by: Waleed Ammar, et al.
Published: (2014-03-01)

Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
by: Yao Hu, et al.
Published: (2020-10-01)

Association between Osteoprotegerin gene polymorphisms and risk of coronary artery disease: A systematic review and meta-analysis
by: Jia P, et al.
Published: (2017-12-01)

The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome
by: Gültekin Adanaş Aydın, et al.
Published: (2020-06-01)

Effects of osteoprotegerin on implant osseointegration in ovariectomized rats
by: LI Yun⁃fen
Published: (2016-11-01)

Régulation de l'expression du gène de l'ostéoprotégérine dans les cellules ostéosarcomateuses MG-63
by: Lambert, Cecile
Published: (2008)

Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
by: Eman H El-Adawy, et al.
Published: (2017-01-01)

Plasma Osteoprotegerin Levels Before and After Treatment of Thyroid Dysfunctions
by: Didem Özdemir, et al.
Published: (2013-12-01)

EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01)

The effect of osteoprotegerin on implant osseointegration in ovariectomized rats
by: Yiming Liu, et al.
Published: (2017-01-01)

Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus
by: Binbin Huang, et al.
Published: (2020-09-01)

The Osteoprotegerin - Von Willebrand Factor Complex: Protagonist Or Bystander In Atherothrombosis?
by: Nagy Elod
Published: (2016-06-01)

Effects of Aldosterone, Osteoprotegerin and Fibroblast Growth Factor-23 and Some Biochemical Markers in Chronic Kidney Disease Patients (Stage II-IV) among Patients with or without Cardiovascular Events
by: Zeyad A. Ameen, et al.
Published: (2018-12-01)

Role of Serum Osteoprotegerin as a Diagnostic Indicator of Primary Osteoporosis in Perimenopausal and Postmenopausal Women: An Indian Perspective
by: Pandey A, et al.
Published: (2018-03-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

Gingival crevicularfluid osteoprotegerin levels in Indian population
by: Purnima Bandari, et al.
Published: (2012-01-01)

Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
by: Tarek Z. El Baz, et al.
Published: (2017-06-01)

RANK, RANKL and osteoprotegerin in arthritic bone loss
by: M.C. Bezerra, et al.
Published: (2005-02-01)

The Role of Osteoprotegerin and Its Ligands in Vascular Function
by: Luc Rochette, et al.
Published: (2019-02-01)

Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity
by: Binghan Li, et al.
Published: (2016-04-01)

Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis
by: Xue-Rong Wang, et al.
Published: (2019-01-01)

THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01)

The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
by: Migacz Maciej, et al.
Published: (2020-05-01)

Comparison of Serum Levels of Osteoprotegerin, Insulin, Triglyceride, and Cholesterol in Obese and Non-obese Children
by: Nooshin Nesaee, et al.
Published: (2021-07-01)

Dickkopf-1 levels and serum Osteoprotegerin in women with Osteoporosis
by: Mehrzad Hajialilo, et al.
Published: (2013-12-01)

Osteoclast activity in osteoporosis mandibular bone based on RANKL and osteoprotegerin ratio.
by: Mefina Kuntjoro, et al.
Published: (2021-11-01)

Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis
by: Xiao-Hong Xu, et al.
Published: (2020-11-01)

Association of Red Meat Intake with the Risk of Cardiovascular Mortality in General Japanese Stratified by Kidney Function: NIPPON DATA80
by: Hiroyoshi Segawa, et al.
Published: (2020-11-01)

Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis
by: Wei-Chen Lin, et al.
Published: (2020-01-01)